Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Arginine + sodium succinate) by Polysan for Atherosclerosis: Likelihood of Approval
(Arginine + sodium succinate) is under clinical development by Polysan and currently in Phase II for Atherosclerosis. According to GlobalData,...